Stereotaxis to Participate at BTIG’s 2016 MedTech Conference

ST. LOUIS, Feb. 16, 2016 -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that William C. Mills, CEO, and Martin C. Stammer, CFO, will participate in BTIG’s 2016 MedTech Conference on Thursday, February 25, 2016. 

The conference is being held from February 24-26, 2016 at The Cliff Lodge Hotel in Snowbird, Utah, and consists of a full day of one-on-one meetings.

About Stereotaxis

Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. Over 100 issued patents support the Stereotaxis platform, which helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Stereotaxis' core Epoch^® Solution includes the Niobe^® ES remote magnetic navigation system, the Odyssey^® portfolio of lab optimization, networking and patient information management systems, and the Vdrive^® robotic navigation system and consumables.

The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Canada, China, Japan, and elsewhere. The V-Sono^™ ICE catheter manipulator, V-Loop^™ variable loop catheter manipulator, and V-CAS^™ catheter advancement system have received clearance in the United States, Canada, and the European Union. For more information, please visit www.stereotaxis.com.

Press Contact:
Martin Stammer
Chief Financial Officer
314-678-6155

Investor Contact:
Todd Kehrli / Jim Byers
MKR Group, Inc.
323-468-2300
[email protected]